CGM with DM education for Diabetes Mellitus

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of Washington Diabetes Institute, Seattle, WA
Diabetes Mellitus+2 More
Dexcom G6 - Device
Eligibility
18 - 65
All Sexes
What conditions do you have?
Select

Study Summary

Determine the impact of the Compañeros en Salud (Partners in Health) curriculum in conjunction with RT-CGM on glycemic control in Latinx patients with T2D. Participants will be randomized to receive the Companeros en Salud diabetes self-management education and support (DSMES) intervention with or without RT-CGM

Eligible Conditions

  • Diabetes Mellitus
  • Diabetes Type 2

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: change at 12 and 24 weeks

Week 24
CGM indices
Week 24
A1C

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Education only
1 of 2
CGM with DM education
1 of 2
Active Control

100 Total Participants · 2 Treatment Groups

Primary Treatment: CGM with DM education · No Placebo Group · N/A

Education onlyNoIntervention Group · 1 Intervention: Education only · Intervention Types:
CGM with DM education
Device
ActiveComparator Group · 1 Intervention: Dexcom G6 · Intervention Types: Device

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: change at 12 and 24 weeks

Trial Background

Prof. Nicole Ehrhardt, Assistant Professor of Medicine
Principal Investigator
University of Washington
Closest Location: University of Washington Diabetes Institute · Seattle, WA
Photo of Seattle  1Photo of Seattle  2Photo of Seattle  3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Diabetes Mellitus
0 CompletedClinical Trials

Eligibility Criteria

Age 18 - 65 · All Participants · 7 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are at least 18 years old.
You have had a clinical diagnosis of type 2 diabetes for at least 5 years.
You have access to a personal device that allows attending educational sessions virtually.
You are able to monitor your own glucose levels using the CGM device.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.